Our observations confirm that biallelic ATP8A2 mutations cause a distinct clinical phenotype that is characterized by global developmental delays, severe hypotonia, optic atrophy and hyperkinetic movement disorders. The gene discussed is ATP8A2; the disease is hereditary optic atrophy.